HCM
ACUR

Highbridge Capital Management’s Acura Pharmaceuticals ACUR Stock Holding History

Highbridge Capital Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27,114
Closed -$68K – 2059
2015
Q4 		$68K Sell
27,114
-15,724
-37% -$38.2K ﹤0.01% 1434
2015
Q3 		$101K Buy
+42,838
New +$146K ﹤0.01% 1434

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highbridge Capital Management's ACUR Position: Q1 2016 in Review

Highbridge Capital Management sold out of Acura Pharmaceuticals (ACUR) in Q1 2016, closing a stake of 27,114 shares — an estimated $68K sold.

Highbridge Capital Management first reported a position in ACUR in Q3 2015 and held it in 2 quarters. The position peaked at $101K in Q3 2015. 22 funds tracked by Wall St. Rank hold ACUR as of Q1 2016.

  • Highbridge Capital Management reported no remaining Acura Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 27,114 Acura Pharmaceuticals shares in Q1 2016, an estimated $68K.
  • Highbridge Capital Management first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Highbridge Capital Management's Acura Pharmaceuticals position peaked at $101K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.